400-168-8906
siRNA > Order

In the field of gene function research and drug development, the primary advantage of siRNA over small molecule inhibitors, chemical drugs and antibodies is its high specificity and high throughput screening. siRNA can optimize the position and modification mode of RNAi targeted sequence, achieve gene expression silencing for different target genes, and further develop new drugs rapidly, and its screening and development time is usually better than chemical drugs and antibody drugs.


siRNA   service

 Regular siRNA

Modified siRNA

UHP siRNA

Animal-grade in vivo-siRNA

Application

Suitable for preliminary screening of RNAi in various cells

Increase siRNA stability and effectively inhibit target gene expression

Ensure ultra-high performance of silencing specificity, efficiency and stability of each siRNA sequence

Can be injected directly into the animal for systemic or partial drug delivery






Advantages

1. Using professional technical design, specially optimized sequences and modifications to ensure that siRNA can achieve more than 70% silencing effect;

2. Design and synthesize siRNA for more regions of the same mRNA to improve the success rate of silencing target genes;

3.If the silencing effect of the 3 pairs of Sirnas in the kit is less than 70% in any cell line, we will redesign and synthesize an additional 3 pairs of Sirnas for the target gene for free and give them away for control. We will judge according to the experimental data you provide [you can choose one or the other, which needs to reach 80% transfection efficiency or positive interference effect reaches 70%] and qPCR primers and original results)





Service Details

S/N

Services

Specification

PRsi001

siRNA regular single-target synthesis

2.5nmol
  5nmol
  10nmol
  100nmol
  Others

PRsiu002

UHP- siRNA chemical modified single-target synthesis

2.5nmol
  5nmol
  10nmol
  100nmol
  Others

PRsit003

siRNA   regular 1/3 package synthesis

5nmol*3

PRsit003

siRNA   regular 2/5 package synthesis

5nmol*5

PRsit004

siRNA   regular 1/3 ready-to-use package synthesis

5nmol*3

PRsit004

siRNA   regular 2/5 Ready-to-Use Package Synthesis

5nmol*5

Prsiut005

UHP-siRNA   chemical modified 1/3 package synthesis

5nmol*3

Prsiut005

UHP-siRNA   chemical modified 2/5 package synthesis

5nmol*5

Prsiut006

UHP-siRNA   chemical modified 1/3 ready-to-use package synthesis

5nmol*3

Prsiut006

UHP-siRNA   chemical modified 2/5 ready-to-use package synthesis

5nmol*5